Core Viewpoint - Aide Technology Co., Ltd. (爱得科技) has successfully listed on the Beijing Stock Exchange, with a closing price of 21.23 yuan, reflecting a significant increase of 176.79% on its first day of trading, and a total market capitalization of 2.508 billion yuan [1]. Company Overview - Aide Technology specializes in the research, production, and sales of orthopedic medical devices, focusing on products such as spinal, trauma, and sports medicine consumables, as well as wound healing products [1]. - The company aims to become a leading provider of comprehensive orthopedic surgical solutions in China, guided by clinical needs in orthopedics [1]. Shareholding Structure - As of the signing date of the prospectus, Lu Qiang holds 34.99% and Huang Meiyu holds 38.78% of the shares directly, with an additional 5.29% controlled through a management company, totaling 79.07% of shares held or controlled by the couple, who are the controlling shareholders [1]. Financial Highlights - The company reported revenues of 285.60 million yuan in 2022, 262.11 million yuan in 2023, and projected revenues of 307.48 million yuan for 2025, indicating an expected growth of 11.87% compared to 2024 [5][7]. - Net profits for the same periods were 93.39 million yuan (2022), 63.57 million yuan (2023), and a projected 76.51 million yuan for 2025, reflecting a growth of 14.56% from 2024 [5][7]. - The company’s total assets as of June 30, 2025, were approximately 652.06 million yuan, with total equity of about 543.81 million yuan [6]. Fundraising and Investment Plans - Aide Technology issued 29,530,762 shares at a price of 7.67 yuan per share, raising a total of approximately 226.50 million yuan, with a net amount of about 196.99 million yuan after expenses [2]. - The funds will be allocated to three main projects: orthopedic consumables expansion (approximately 102.48 million yuan), research center construction (approximately 52.66 million yuan), and marketing network development (approximately 41.88 million yuan) [4].

Group 1 - The core focus of Zhangjiagang is on economic development, emphasizing the "one competition, four continuities, and five pioneers" strategy for the new year [1] - The city aims to accelerate the construction of a "5+5+N" industrial system, promoting the large-scale development of biomedicine and high-end medical devices [5] - The successful listing of Aide Technology on the Beijing Stock Exchange marks it as the first stock of the year from Zhangjiagang, symbolizing a new starting point for the company [3][5] Group 2 - City leaders express commitment to support local enterprises in financing, listing cultivation, and standardized operations, aiming to facilitate more local companies to connect with capital markets [5] - Aide Technology's chairman emphasizes the importance of maintaining good governance and enhancing profitability and competitiveness post-listing [5] - The local government plans to continue its "three services" initiative to support enterprise development and promote high-quality growth in the region [5]

Group 1: Linping Development (603284) - Linping Development focuses on the research, production, and sales of corrugated paper and boxboard products, recognized as a high-tech enterprise with independent R&D capabilities [2] - The company is controlled by Li Jianshe, who holds 84.86% of the shares directly and an additional 3.54% indirectly, totaling 88.40% of the voting rights [2] - The total funds raised by Linping Development amount to 714.18 million yuan, with a net amount of 624.09 million yuan allocated for projects including the annual production of 900,000 tons of green intelligent manufacturing new materials [2] Group 2: Electric Science Blue Sky (688818) - Electric Science Blue Sky specializes in the R&D, production, sales, and services of electric energy products and systems, covering applications from deep sea to deep space [3] - The company is primarily controlled by China Electronics Technology Group Corporation, which holds 48.97% of the shares directly and additional indirect holdings, resulting in a total control of 84.50% of the voting rights [3] - The total funds raised by Electric Science Blue Sky are 1.64 billion yuan, with a net amount of 1.58 billion yuan designated for the industrialization of aerospace power systems [4] Group 3: Aide Technology (920180) - Aide Technology is engaged in the R&D, production, and sales of orthopedic medical devices, focusing on products such as spinal, trauma, and sports medicine consumables [5] - The company is controlled by Lu Qiang and Huang Meiyu, who together hold 79.07% of the shares before the issuance, with a reduction to 59.30% post-issuance [5] - The total funds raised by Aide Technology amount to 226.50 million yuan, with a net amount of 196.99 million yuan allocated for projects including the expansion of orthopedic consumables production and the establishment of a research center [5]

M 发行价格 37.8٤ 留签率 0.02 总市值 28.57 发行市盈率 18.6 1、伴随"以纸代 经济政策。 2、依托安徽宿州 年产量占安徽省线 业务及亮点 发行价格 9.47 中签率 0.03 总市值 164.5 发行市盈率 56.7 业务及亮点 1、公司前身由中 业务，是电科旗T 2、背靠中国电科 域覆盖深海至深空 3、持续提升宇航 完成在轨验证，同 4、产品服务于神 空间飞行器电源领 7.67 0.02 郎签率 *免责声明：文章内容仅供参考，不构成投资建议 *风险提示：股市有风险，入市需谨慎 深耕行业20余 3、 系，位列全国造纤 4、募投项目投产 力有望进一步提升 发行价格 ...

Group 1: New Stock Listings - Three new stocks are listed today: Linping Development on the Shanghai Stock Exchange, Dianke Lantian on the Sci-Tech Innovation Board, and Aide Technology on the Beijing Stock Exchange [1][2][5] Group 2: Linping Development - Linping Development is a leading paper manufacturing company in Anhui Province, focusing on the research, production, and sales of corrugated paper and boxboard products [1] - The company achieved revenues of 2.879 billion yuan, 2.800 billion yuan, and 2.485 billion yuan for the years 2022, 2023, and 2024 respectively, with net profits of 154 million yuan, 212 million yuan, and 153 million yuan [1] - For 2025, the company forecasts a revenue growth of 6.23% to 2.87 billion yuan and a net profit increase of 17.76% to 2.12 billion yuan [1] Group 3: Dianke Lantian - Dianke Lantian is a leader in aerospace power systems in China, with products including space solar battery arrays and lithium-ion battery packs, serving national and commercial aerospace sectors [1] - The company has become a major supplier for large satellite constellations, supporting over 700 spacecraft and covering significant national projects [1] - The aerospace power business accounted for 74% of the company's revenue, with a domestic market share exceeding 50% [1] Group 4: Aide Technology - Aide Technology specializes in the research, production, and sales of orthopedic medical devices, focusing on spinal, trauma, and sports medicine products [2][6] - The company reported revenues of 262.1 million yuan, 274.9 million yuan, and 301.7 million yuan for the years 2023, 2024, and 2025 respectively, with net profits of 63.57 million yuan, 67.13 million yuan, and 77.75 million yuan [2] - The company forecasts a revenue growth of 0.35% to 3.85 million yuan for 2025, while net profit is expected to fluctuate between -3.18% to 6.81% [2]

今日爱得科技(920180.BJ)、 电科蓝天(688818.SH)、 林平发展(603284.SH)上市，无新股申购。 ...

Group 1: Linping Development (603284.SH) - Linping Development specializes in the research, production, and sales of corrugated paper and boxboard products, recognized as a high-tech enterprise with independent R&D capabilities [4][6] - The company has a market capitalization of 28.57 billion yuan and an issue price of 37.88 yuan per share, with an issuance P/E ratio of 18.69 [4] - Linping Development's production capacity is 1.15 million tons, ranking among the top 30 paper production companies in China, with a projected raw paper output of 1.0197 million tons for 2024 [6] - The company has established stable partnerships with well-known domestic enterprises, enhancing its brand influence and competitive advantage [6] Group 2: Electric Science Blue Sky (688818.SH) - Electric Science Blue Sky focuses on advanced electric energy systems and products, with a market capitalization of 164.50 billion yuan and an issue price of 9.47 yuan per share [9] - The company has a high concentration of sales to its largest customer, Aerospace Science and Technology Group, which accounted for 45.59% of its revenue in 2022 [12] - Electric Science Blue Sky has a strong technological foundation with 367 authorized patents and has received multiple national science and technology awards [12] Group 3: Aide Technology (920180.BJ) - Aide Technology is engaged in the R&D, production, and sales of orthopedic medical devices, with a market capitalization of 7.67 billion yuan and an issue price of 7.67 yuan per share [16] - The company ranks third among domestic manufacturers of spinal vertebral body shaping systems and has a stable customer base with no single customer exceeding 50% of total sales [17] - Aide Technology holds 108 patents, including 41 invention patents, and is subject to strict regulatory oversight from health authorities [17]